Found 48 matching trials
89Zr-DFO-girentuximab Expanded Access Program (EAP) N/A The purpose of this Expanded Access Program (EAP) is to enable the use of 8...
Show More Status
No Longer Available
Learn More & Join Trial
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases NA This study aims to evaluate the diagnostic potential of 68-Gallium PSMA-PET...
Show More Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Learn More & Join Trial
Tracking Endothelial Cells in Arterial Injury NA We plan to track the migratory behaviour of culture-expanded enothelial out...
Show More Location
University of Edinburgh
Learn More & Join Trial
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET NA Accurate staging is of great importance in patients with clinically locally...
Show More Location
VU University Medical Center
Learn More & Join Trial
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer. NA The goal of this study type: observational study (prospective study) is to ...
Show More Location
First affiliated hospital of anhui university
Learn More & Join Trial
FAPI PET Imaging - An Exploratory Study PHASE1 This study is testing a new imaging tracer called \[18F\]FAPI-74 with PET s...
Show More Location
Kantonsspital Baden
Learn More & Join Trial
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN NA Precision medicine represents a major goal in oncology. It has its underpin...
Show More Learn More & Join Trial
PET-imaging of Two Vartumabs in Patients With Solid Tumors EARLY_PHASE1 VARTUTRACE is a first-in-human PET/CT molecular imaging study in patients w...
Show More Location
University Medical Center Groningen (UMCG)
Learn More & Join Trial
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases NA The great promise of PET/MR for assessment of skeletal metastatic involveme...
Show More Location
Multiple Locations
Learn More & Join Trial
PD-L1 Expression in Lung Cancer PHASE2 This study will measure PD-L1 expression in metastatic NSCLC (primary tumou...
Show More Location
Guy's and St Thomas' NHS Foundation Trust
Learn More & Join Trial